COPPSERS
ADAP

Commonwealth of Pennsylvania Public School Employees Retirement System’s Adaptimmune Therapeutics ADAP Stock Holding History

Commonwealth of Pennsylvania Public School Employees Retirement System’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,287
Closed -$15.6K – 1653
2023
Q1 		$15.6K Buy
+14,287
New +$22.1K ﹤0.01% 1723

Other funds holding ADAP

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System's ADAP Position: Q2 2023 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System sold out of Adaptimmune Therapeutics (ADAP) in Q2 2023, closing a stake of 14,287 shares — an estimated $15.6K sold.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in ADAP in Q1 2023 and held it in 1 quarter. The position peaked at $15.6K in Q1 2023. 89 funds tracked by Wall St. Rank hold ADAP as of Q2 2023.

  • Commonwealth of Pennsylvania Public School Employees Retirement System reported no remaining Adaptimmune Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Commonwealth of Pennsylvania Public School Employees Retirement System sold 14,287 Adaptimmune Therapeutics shares in Q2 2023, an estimated $15.6K.
  • Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in Adaptimmune Therapeutics in Q1 2023 and held it in 1 quarter.
  • Commonwealth of Pennsylvania Public School Employees Retirement System's Adaptimmune Therapeutics position peaked at $15.6K in Q1 2023.
  • 89 funds tracked by Wall St. Rank held Adaptimmune Therapeutics as of Q2 2023.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q2 2023, filed 9 Aug 2023.